Kcs Wealth Advisory Novo Nordisk A S Transaction History

Kcs Wealth Advisory

$224 Million
Q3 2023

A detailed history of Kcs Wealth Advisory transactions in Novo Nordisk A S stock. As of the latest transaction made, Kcs Wealth Advisory holds 40,974 shares of NVO stock, worth $3.58 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares

40,974

Previous 22,918 78.79%

Holding current value

$3.58 Million

Previous $3.71 Million 0.49%

% of portfolio

1.66%

Previous 1.35%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$90.94 - $199.54 $1.64 Million - $3.6 Million	18,056 Added 78.79%	40,974 $3.73 Million
Q2 2023 Jul 17, 2023	SELL	$155.98 - $172.65 $56,152 - $62,154	-360 Reduced 1.55%	22,918 $3.71 Million
Q1 2023 Apr 17, 2023	SELL	$132.34 - $159.14 $19,586 - $23,552	-148 Reduced 0.63%	23,278 $3.7 Million
Q4 2022 Feb 07, 2023	SELL	$102.55 - $135.33 $352,259 - $464,858	-3,435 Reduced 12.79%	23,426 $3.17 Million
Q3 2022 Oct 21, 2022	SELL	$95.28 - $116.93 $308,993 - $379,203	-3,243 Reduced 10.77%	26,861 $2.68 Million
Q2 2022 Jul 22, 2022	BUY	$103.24 - $121.81 $49,968 - $58,956	484 Added 1.63%	30,104 $3.35 Million
Q1 2022 Apr 13, 2022	BUY	$93.1 - $112.54 $141,232 - $170,723	1,517 Added 5.4%	29,620 $3.29 Million
Q4 2021 Jan 26, 2022	BUY	$95.88 - $117.08 $59,925 - $73,175	625 Added 2.27%	28,103 $3.15 Million
Q3 2021 Oct 20, 2021	BUY	$84.42 - $106.62 $121,733 - $153,746	1,442 Added 5.54%	27,478 $2.64 Million
Q2 2021 Jul 27, 2021	BUY	$67.66 - $84.76 $324,565 - $406,593	4,797 Added 22.59%	26,036 $2.18 Million
Q1 2021 Apr 19, 2021	BUY	$67.06 - $75.82 $869,499 - $983,082	12,966 Added 156.73%	21,239 $1.43 Million
Q4 2020 Jan 28, 2021	BUY	$63.89 - $73.8 $338,169 - $390,623	5,293 Added 177.62%	8,273 $578,000
Q3 2020 Oct 27, 2020	SELL	$63.69 - $70.22 $57,575 - $63,478	-904 Reduced 23.27%	2,980 $207,000
Q1 2020 Apr 28, 2020	SELL	$49.46 - $64.78 $34,572 - $45,281	-699 Reduced 15.25%	3,884 $234,000
Q4 2019 Jan 15, 2020	SELL	$49.86 - $58.26 $19,096 - $22,313	-383 Reduced 7.71%	4,583 $265,000
Q3 2019 Oct 29, 2019	SELL	$47.54 - $53.43 $2,852 - $3,205	-60 Reduced 1.19%	4,966 $256,000
Q1 2019 Apr 29, 2019	SELL	$46.36 - $52.63 $8,530 - $9,683	-184 Reduced 3.53%	5,026 $263,000
Q4 2018 Jan 17, 2019	SELL	$41.54 - $47.25 $30,781 - $35,012	-741 Reduced 12.45%	5,210 $240,000
Q3 2018 Nov 06, 2018	SELL	$46.76 - $51.24 $140,841 - $154,334	-3,012 Reduced 33.6%	5,951 $281,000
Q2 2018 Aug 07, 2018	SELL	$44.29 - $50.42 $102,442 - $116,621	-2,313 Reduced 20.51%	8,963 $413,000
Q1 2018 May 04, 2018	SELL	$48.49 - $58.14 $64,346 - $77,151	-1,327 Reduced 10.53%	11,276 $555,000
Q4 2017 Jan 12, 2018	BUY	$47.53 - $53.73 $599,020 - $677,159	12,603	12,603 $676,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcs Wealth Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Kcs Wealth Advisory with notifications on news.

Account

Kcs Wealth Advisory Novo Nordisk A S Transaction History